Therapy leaders are hailing results of a new study showing outcomes were not harmed during the first five months of the Patient-Driven Payment Model.
At the same time, they caution that deeper examination is needed under non-pandemic conditions. And they reject any notion that therapy was over-applied under the previous Medicare reimbursement system.
“Overall, I think it’s really positive to see a study that highlights the changes that occurred around a regulatory shift weren’t detrimental to patient outcomes,” said Tracy Fritts, vice president of quality and outcomes for Consonus Healthcare. Her company provides rehabilitation, pharmacy and consulting services in more than 700 facilities nationwide. “I’m super excited to see that. It’s a question we were all asking. I think (the study) had a lot of purpose and solid methodology.”